Retatrutide: The Complete UAE Research Reference

Overview

Retatrutide (development code LY3437943) is an investigational triple-agonist peptide studied for its effects on metabolic regulation and energy expenditure. It is supplied by Body Labs UAE strictly for in-vitro and laboratory research.

Unlike single-agonist or dual-agonist compounds, retatrutide engages three metabolic receptors simultaneously, which is the basis for much of the current research interest in the compound.

Mechanism of Action

Retatrutide activates the GIP receptor (GIPR), the GLP-1 receptor (GLP-1R), and the glucagon receptor (GCGR). The glucagon component is the most distinctive: in laboratory models, GCGR activation is associated with hepatic glucose output, thermogenesis, and changes in hepatic fat fraction relevant to NAFLD and MASH research.

Research Applications

Reported research areas include metabolic-pathway modulation studies, body-composition and energy-expenditure research, appetite-signalling mechanism analysis, and multi-receptor agonist pharmacology. All applications are pre-clinical or laboratory in nature.

Pen Format, Handling and CoA

Body Labs supplies retatrutide as a 32mg pre-filled research pen for precise, repeatable volume delivery, with no reconstitution required. Store refrigerated at 2 to 8C, away from light, and do not freeze. Each batch ships with a Certificate of Analysis: a Janoshik third-party report plus in-house HPLC, batch-traceable by report number.